Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
Amphastar Pharmaceuticals (AMPH) - Cash on Hand
Cash on Hand as of December 2023 : $0.25 B
According to Amphastar Pharmaceuticals's latest financial reports the company has $0.25 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Amphastar Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.25 B | 46.11% |
| 2022-12-31 | $0.17 B | 28.6% |
| 2021-12-31 | $0.13 B | 29.4% |
| 2020-12-31 | $0.10 B | 23.73% |
| 2019-12-31 | $85.36 M | -4.27% |
| 2018-12-31 | $89.16 M | 30.69% |
| 2017-12-31 | $68.22 M | -6.38% |
| 2016-12-31 | $72.88 M | 10.3% |
| 2015-12-31 | $66.07 M | -2.59% |
| 2014-12-31 | $67.82 M | 26.58% |
| 2013-12-31 | $53.58 M | 6.72% |
| 2012-12-31 | $50.21 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | $6.91 M | -97.31% | 🇺🇸 USA |
 SCYNEXIS SCYX | $88.07 M | -65.70% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | $0.15 B | -41.48% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.87 M | -98.88% | 🇺🇸 USA |